In a recent Harris poll, health insurance providers
ranked highest among entities in the healthcare industry in public
distrust. Consumers rank insurers as one the most untrustworthy
providers, putting them at the bottom of the barrel.
59%
of adult survey respondents say that their general trust for insurance
companies is either “not much” or “not at all”, while 29% say that
their own trust level of their insurance company is “not much” or “not
at all”.
The nationwide poll of
2,343 U.S. adults was conducted in January of 2004 by Harris
Interactive on behalf of The Wall Street Journal Online’s Health
Industry edition.
For individual providers, nurses edged out doctors as being ranked lowest in public distrust.
Humphrey
Taylor, chairman of The Harris Poll says, “the most striking poll
results relate to insurers and pharmaceuticals.” Taylor cited the
result that only 7% of survey respondents indicated they mistrust the
prescriptions they take compared to 41% who distrust the pharmaceutical
companies who produce them. “Fully 59% do not trust health
insurers in general, but only 29% do not trust their own insurer,”
Taylor continued.
|
|
A lot |
Some |
Not Much |
Not at all |
Not sure |
Not applicable |
Your doctor or doctors |
% |
63 |
26 |
4 |
1 |
2 |
3 |
Nurses who treat you |
% |
60 |
29 |
3 |
1 |
1 |
6 |
Your dentist |
% |
58 |
29 |
3 |
1 |
3 |
7 |
The pharmacy or pharmacies that you use |
% |
50 |
36 |
6 |
2 |
2 |
4 |
The last hospital where you were treated |
% |
47 |
33 |
7 |
4 |
2 |
7 |
The prescription drugs you take |
% |
44 |
36 |
5 |
2 |
2 |
12 |
Your employer |
% |
16 |
29 |
17 |
8 |
2 |
27 |
Your health insurer |
% |
15 |
35 |
25 |
12 |
4 |
9 |
Your managed care company |
% |
9 |
25 |
19 |
10 |
4 |
33 |
For its part, the new head of the pharmaceutical industry's trade association has said
the industry needs to recapture the trust of the American public.
That
doesn't mean the industry will change its opposition to such popular
initiatives as allowing drugs to be imported from other countries or
letting the government negotiate lower prices for the new Medicare
prescription drug benefit.
What it does
mean, said Billy Tauzin, president of the Pharmaceutical Research and
Manufacturers of America, is the industry will support other ways to
help Americans pay for their medicines.